Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
3.150
0.00 (0.00%)
At close: Dec 16, 2025, 4:00 PM EST
3.090
-0.060 (-1.90%)
After-hours: Dec 16, 2025, 7:39 PM EST
Lipocine Market Cap
Lipocine has a market cap or net worth of $17.49 million as of December 16, 2025. Its market cap has decreased by -26.52% in one year.
Market Cap
17.49M
Enterprise Value
3.21M
1-Year Change
-26.52%
Ranking
Category
Stock Price
$3.15
Market Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $17.49M, a decrease of -78.75%. That is a compound annual growth rate of -12.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 17.50M | -32.95% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
| Mar 21, 2014 | 82.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |